Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Renal Function in Kidney Transplantation
NCT05935293Phase 4Not yet recruiting
- Start
- Dec 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of dexmedetomidine in acute kidney injury (AKI), delayed graft function (DGF). Planned start Dec 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
acute kidney injury (AKI)delayed graft function (DGF)
Beyond the preview
Go deeper on NCT05935293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05935293.